VHCP Management, LLC current holdings: USA Other Stocks
VHCP Management, LLC reported $0.07 billion in shares no fund filing gives a ticker for, so this site has no page for them (listed in the US), 18 positions, in its Form 13F for the quarter ended 2016-09-30; the largest are DBV Technologies, Flamel Technologies S.A., Adverum Biotechnologies.
- DBV Technologies: Country of operation —; Class COM; Shares 456,893; Value $32,492,000.
- Flamel Technologies S.A.: Country of operation —; Class COM; Shares 500,000; Value $6,200,000.
- Adverum Biotechnologies: Country of operation —; Class COM; Shares 1,102,735; Value $4,532,000.
- Lipocine Inc: Country of operation —; Class COM; Shares 849,921; Value $3,791,000.
Form 13F-HR as filed (SEC CIK 1479355): quarter ended 2016-09-30, filed 2016-11-14. The manager files one row per sub-manager; rows for the same security, class and put/call are added together.
| Stock | Country of operation | Class | Shares | Value | Quarter end | Filed |
|---|
DBV Technologies
CUSIP F2927N109 | | COM | 456,893 | $32,492,000 | 2016-09-30 | 2016-11-14 |
|---|
Flamel Technologies S.A.
CUSIP 338488109 | | COM | 500,000 | $6,200,000 | 2016-09-30 | 2016-11-14 |
|---|
Adverum Biotechnologies
CUSIP 00773U108 | | COM | 1,102,735 | $4,532,000 | 2016-09-30 | 2016-11-14 |
|---|
Lipocine Inc
CUSIP 53630X104 | | COM | 849,921 | $3,791,000 | 2016-09-30 | 2016-11-14 |
|---|
CoLucid Pharmaceuticals
CUSIP 19716T101 | | COM | 68,190 | $2,601,000 | 2016-09-30 | 2016-11-14 |
|---|
Axovant Sciences Ltd
CUSIP G0750W104 | | COM | 184,110 | $2,578,000 | 2016-09-30 | 2016-11-14 |
|---|
Ocera Therapeutics
CUSIP 67552A108 | | COM | 856,550 | $2,261,000 | 2016-09-30 | 2016-11-14 |
|---|
Zafgen Inc
CUSIP 98885E103 | | COM | 602,114 | $1,993,000 | 2016-09-30 | 2016-11-14 |
|---|
Ascendis Pharma A/S
CUSIP 04351P101 | | COM | 90,000 | $1,809,000 | 2016-09-30 | 2016-11-14 |
|---|
Alcobra Ltd
CUSIP M2239P109 | | COM | 658,910 | $1,628,000 | 2016-09-30 | 2016-11-14 |
|---|
Stemline Therapeutics Inc
CUSIP 85858C107 | | COM | 135,420 | $1,467,000 | 2016-09-30 | 2016-11-14 |
|---|
Achillion Pharmaceuticals Inc
CUSIP 00448Q201 | | COM | 180,000 | $1,458,000 | 2016-09-30 | 2016-11-14 |
|---|
Edge Therapeutics Inc
CUSIP 279870109 | | COM | 135,000 | $1,405,000 | 2016-09-30 | 2016-11-14 |
|---|
Akari Therapeutics Plc
CUSIP 00972G108 | | COM | 158,352 | $1,348,000 | 2016-09-30 | 2016-11-14 |
|---|
ARCA biopharma Inc
CUSIP 00211Y100 | | COM | 462,399 | $1,309,000 | 2016-09-30 | 2016-11-14 |
|---|
Audentes Therapeutics
CUSIP 05070R104 | | COM | 15,000 | $267,000 | 2016-09-30 | 2016-11-14 |
|---|
ProNAI Therapeutics Inc
CUSIP 74346L101 | | COM | 56,056 | $102,000 | 2016-09-30 | 2016-11-14 |
|---|
Aeglea BioTherapeutics
CUSIP 00773J103 | United States | COM | 6,000 | $38,000 | 2016-09-30 | 2016-11-14 |
|---|
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|
| Not available yet |